🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the efficacy and safety of mosunetuzumab in combinat...
Status
Active Not Recruiting
Location
City of Hope Cancer Center
Start Date
2022-04-25
Trial ID
NCT05171647
Treatments Being Tested
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Start Date
2022-06-14
Trial ID
NCT05283720
This phase I trial studies the best dose and how well bendamustine works wi...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2009-02-17
Trial ID
NCT00880815
Primary Objective: To evaluate the effect of caplacizumab on prevention of...
Status
Completed
Location
Investigational Site Number 3920009
Start Date
2019-10-21
Trial ID
NCT04074187
This phase I/Ib trial studies the side effects and best dose of parsaclisib...
Status
Active Not Recruiting
Location
Mayo Clinic in Arizona
Start Date
2020-06-15
Trial ID
NCT04323956
This study will test if adding ruxolitinib to standard multi-drug chemother...
Status
Recruiting
Location
University of Chicago Medical Center
Start Date
2019-05-28
Trial ID
NCT03571321
Monoclonal antibodies such as rituximab can locate cancer cells and either ...
Status
Completed
Location
Ohio State University Medical Center
Start Date
2000-12
Trial ID
NCT00010192
Treatments Being Tested
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells ...
Status
Active Not Recruiting
Location
University of Arizona Cancer Center - North Campus /ID# 227463
Start Date
2023-02-08
Trial ID
NCT05578976
Treatments Being Tested
This study is a phase III, randomized, open-label, international, multicent...
Status
Recruiting
Location
Krankenhaus der Barmherzigen Brüder Graz - Abteilung Für Innere Medizin I
Start Date
2024-06-07
Trial ID
NCT06284122
Patient will receive either one infusion of rituximab IV and seven administ...
Status
Completed
Location
CH de Pays d'Aix
Start Date
2015-02-02
Trial ID
NCT02303119
Treatments Being Tested